Thursday, November 19

The World Health Organisation has warned that millions of patients remain at risk of ineffective treatment for drug-resistant infections despite a significant increase in the number of countries with national plans to tackle antimicrobial resistance.

The WHO said only 22 per cent of countries had both the necessary funding and had fully implemented their national antimicrobial resistance action plans, leaving major gaps in the prevention, diagnosis and treatment of resistant infections.

According to new findings from its 2026 Tracking Antimicrobial Resistance Country Self-assessment Survey, 173 countries reported having developed plans to address antimicrobial resistance, more than double the 79 countries recorded in 2017.

However, the global health body said national plans had not translated into adequate protection for patients, specifically in access to diagnostic testing and appropriate treatment.

The report, released ahead of World Antimicrobial Resistance Awareness Week, also found that approximately one in six laboratory-confirmed bacterial infections worldwide was resistant to antibiotics in 2023.

AMR Week is commemorated on

Antimicrobial resistance occurs when bacteria and other microbes no longer respond to medicines used to treat infections, making illnesses harder to manage and increasing the risks associated with routine medical procedures, including surgery, childbirth and cancer care.

The WHO Director-General, Dr Ghebreyesus Tedros, said countries must move beyond developing policies to ensuring that they are fully implemented.

“National plans are essential for protecting the medicines that protect us, and the fact that most countries now have plans in place is great news. But an unfulfilled plan helps no one,” he said.

Tedros called on governments to invest in infection prevention, surveillance, equitable access to essential antimicrobials and quality diagnostic services.

“Every infection prevented means fewer antimicrobials are needed, and testing ensures that patients receive the right treatment only when necessary,” he added.

The survey, completed by 183 countries, representing 94 per cent of WHO member states, found that only 36 per cent had national reference laboratories equipped to test selected bacteria and fungi.

The figure falls short of the global target of having 80 per cent of countries equipped with comprehensive bacterial and fungal resistance testing capacity by 2030.

The WHO warned that inadequate access to diagnostic tests could result in patients receiving antibiotics that are ineffective or unnecessary.

It also noted that resistant infections and outbreaks could go undetected, while limited surveillance data made it difficult to understand local patterns of antimicrobial resistance.

Beyond diagnostic gaps, the findings showed that only 63 per cent of countries had guidelines on the appropriate use of antimicrobials, while just over half had surveillance systems to monitor national antibiotic use and track resistance levels.

To help address the gaps, the WHO released two practical tools under its Antimicrobial Resistance Diagnostic Initiative. The tools provide a prioritised catalogue of diagnostic tests and step-by-step guidance to help clinical laboratories identify bacterial and fungal infections.

World AMR Awareness Week, observed from November 18 to 24, is a global campaign to raise awareness of antimicrobial resistance and encourage action to prevent the emergence and spread of drug-resistant infections.

The 2026 campaign, themed “One Health, one action: Prevent AMR now”, highlights the interconnected health of humans, animals, plants and the environment, and calls on governments, farmers, veterinarians, environmental experts and communities to take action against the threat.

Copyright PUNCH

 

All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten, or redistributed in whole or in part without prior express written permission from PUNCH.

 

 

Share.
Leave A Reply

Exit mobile version